Summary:
Pediatric experience with extracorporeal photochemotherapy (ECP) for graft-versus-host disease (GvHD) has mainly been reported by Italian and French groups. Data concerning 41 children with acute GvHD and 63 children affected by chronic GvHD are available. In 73 and 63% of them, respectively, improvement was observed, with addition of ECP to their immunosuppressive regimen. Treatment with ECP was associated with minimal side effects, even in the smallest of patients. In all responded pediatric patients, both with acute and chronic GvHD, ECP allowed progressive reduction or discontinuation of the concomitant pharmacological immunosuppressive therapy without an increase in GvHD acitivity. These data show that ECP is a useful therapy for children affected by GvHD resistant to conventional treatment and can be safely used.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Rossetti F, Zulian F, Dall'Arnico R et al. Extracorporeal photochemotherapy as single therapy for extensive, cutaneous, chronic graft-versus-host disease. Transplantation 1995; 59: 149–151.
Rossetti F, Dall'Amico R, Crovetti G et al. Extracorporeal photochemistry for the treatment of graft-versus-host disease. Bone Marrow Transplant 1996; 18: 175–181.
Dall'Amico R, F Rossetti, F Zulian et al. Photopheresis in paediatric patients with drug-resistant chronic graft-versus-host disease. Br J Haematol 1997; 97: 848–854.
Perotti C, L Torreta, G Viarengo et al. Feasibility and safety of a new technique of extracorporeal photochemotherapy: experience of 240 procedures. Haematologica 1999; 84: 237–241.
Biagi E, Perseghin P, Buscemi F et al. Effectiveness of extracorporeal photochemotherapy in treating refractory chronic graft-versus-host disease. Haematologica 2000; 85: 329–330.
Salvaneschi L, Perotti C, Zecca M et al. Extracorporeal photochemotherapy for treatment of acute and chronic GVHD in childhood. Transfusion 2001; 41: 1299–1305.
Perutelli P, Rivabella L, Lanino E et al. ATP downregulation in mononuclear cells from children with graft-versus-host disease following extracorporeal photochemotherapy. Haematologica 2002; 87: 335–336.
Perseghin P, Dassi M, Balduzzi A et al. Mononuclear cell collection in patients undergoing extra-corporeal photo-chemotherapy for acute and chronic graft vs host disease: comparison between Cobe Spectra version 4.7 and 6.0 (Auto PBSC). J Clin Apheresis 2002; 17: 65–71.
Messina C, Locatelli F, Lanino E et al. Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation. Br J Haematol 2003; 122: 118–127.
Schooneman F, Claise C . Treatment of graft versus host disease by photopheresis? Transfus Sci 1996; 17: 527–536.
Besnier DP, Chabannes D, Mahe B et al. Treatment of graft-versus-host disease by extracorporeal photochemotherapy: a pilot study. Transplantation 1997; 64: 49–54.
D'incan M, Kanold J, Halle P et al. Extracorporeal photopheresis as an alternative therapy for drug-resistant graft versus host disease: three cases. 2000; 127: 166–170.
Halle P, Paillard C, D'Incan M et al. Successful extracorporeal photochemotherapy for chronic graft-versus-host disease in pediatric patients. J Hematother Stem Cell Res. 2002; 11: 501–512.
Kanold J, Paillard C, Halle P et al. Extracorporeal photochemotherapy for graft versus host disease in pediatric patients. Transfus Apheresis Sci 2003; 28: 71–80.
Kanold J, Halle P, Paillard C et al. Extracorporeal photochemotherapy for graft versus host disease in pediatric patients. Blood 2003: (Supp1. 102) (Abstract).
Balda B, Kostantinov A, Starz H et al. Extracorporeal photochemotherapy as an effective treatment modality in chronic graft versus host disease. J Eur Acad Dermatol Venerol 1996; 7: 155–162.
Looks A, Fuchs D, Rulke D et al. Successful treatment of acute graft versus host disease after bone marrow transplantation in 16-year-old girl with extracorporeal photopheresis. Onkologie 1997; 20: 340–342.
Miller K, Roberts T, Chan G et al. A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host disease. Bone Marrow Transplant 2004; 33: 881–889.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Kanold, J., Messina, C., Halle, P. et al. Update on extracorporeal photochemotherapy for graft-versus-host disease treatment. Bone Marrow Transplant 35 (Suppl 1), S69–S71 (2005). https://doi.org/10.1038/sj.bmt.1704851
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704851
Keywords
This article is cited by
-
Extracorporeal photopheresis (photochemotherapy) in the treatment of acute and chronic graft versus host disease: immunological mechanisms and the results from clinical studies
Cancer Immunology, Immunotherapy (2014)
-
Technology Insight: ECP for the treatment of GvHD—can we offer selective immune control without generalized immunosuppression?
Nature Clinical Practice Oncology (2006)